Neoplasm Metastasis  >>  conatumumab (AMG 655)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
conatumumab (AMG 655) / Amgen
QUILT-2.018, NCT00813605 / 2008-005301-19: Safety & Efficacy of FOLFIRI With AMG 479 or AMG 655 vs FOLFIRI Alone in KRAS-mutant Metastatic Colorectal Carcinoma

Completed
2
155
US, Europe, RoW
FOLFIRI, AMG 655, Conatumumab, Placebo, AMG 479
NantCell, Inc.
Metastatic Colorectal Cancer
01/11
06/12
NCT00819169 / 2008-005074-12: QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors

Terminated
1b/2
89
US, Europe
AMG 479, AMG 655, AMG 655 is also known as conatumumab.
NantCell, Inc.
Colorectal Cancer, Locally Advanced, Metastatic Cancer, Non-Small Cell Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Sarcoma, Solid Tumors
10/10
10/11

Download Options